Nobivac Canine 1-DAPPv+Cv

Description

Nobivac^®: Canine 1-DAPPv+Cv vaccine is a combination vaccine that unites the benefits of Nobivac^®: Canine 1-DAPPv and Nobivac^®: Canine 1-Cv in one vaccination.

Nobivac^®: Canine 1-DAPPv

This vaccine is a modified live virus vaccine for the vaccination of healthy dogs as an aid in the prevention of disease caused by canine distemper virus, adenovirus type 1 (hepatitis), adenovirus type 2 (respiratory disease), canine parainfluenza virus, and canine parvovirus. 

Nobivac^®: Canine 1-Cv

This vaccine  is a killed virus vaccine for the vaccination of healthy dogs as an aid in the prevention of disease caused by canine coronavirus infection. The coronavirus has been chemically inactivated and combined with an adjuvant designed to enhance the immune response.

Dosage and Administration

Shake the Nobivac^®: Canine 1-Cv vial and transfer its contents to the Nobivac^®: Canine 1-DAPPv vial aseptically. Mix gently until dissolved. Use entire contents immediately after rehydration.

Inject one dose (1 mL) subcutaneously or intramuscularly. The initial dose may be given at 6 weeks of age or older. Repeat at 2 to 4 week intervals until the dog is 12 weeks of age. A minimum of two doses is required for primary immunization. Annual revaccination with one dose is recommended. Following the advice of the American Veterinary Medical Association on Vaccination Principles, an appropriate revaccination program for individual animals should be made based upon veterinarian-client-patient relationships.

Do no vaccinate pregnant dogs.

Nobivac Canine 1-DAPPv+Cv is a registered trademark of Intervet Inc., d/b/a Merck Animal Health, a subsidiary of Merck & Co. Inc.